Abstract
Summary
Attention is called to discrepancies arising in mouse assays of botulinum toxin when the method of dilution and choice of diluent are not standardized. As much as 50-fold variation in the toxicity determinations resulted from the use of various diluents in the preparation of the serial dilution. Explanations of some of the discrepancies are suggested.
Get full access to this article
View all access options for this article.